Taken together, these results suggest that CD57 transfer from CD57+ tumor cells to T cells could indeed contribute to CD57 expression on tumor-specific T cells isolated from tumor or lymph node homogenates or PBMCs of patients with CD57+ tumors. The gene discussed is B3GAT1; the disease is neoplasm.